Pharmaceutical Services

• Forward integration of API companies.
• Backward Integration of Finished Dosage Forms ( FP) companies.
• Infrastructure Development ( Man, Machine ).
• QbD Implementation .
• Galenical/Lab scale Oral, Topical and Injectable Formulation Development.
• Formulation Development of NCE
• Bioavailabiltiy Enhancement of API through Formulation.
• Formulation upgradation
• Technology Transfer.
• New Dosage Form
• New Combinations.
• s-New Drug Applications.